Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Med Chem ; 63(20): 11639-11662, 2020 10 22.
Artigo em Inglês | MEDLINE | ID: mdl-32969660

RESUMO

Idiopathic pulmonary fibrosis (IPF) is a rare and devastating chronic lung disease of unknown etiology. Despite the approved treatment options nintedanib and pirfenidone, the medical need for a safe and well-tolerated antifibrotic treatment of IPF remains high. The human prostaglandin F receptor (hFP-R) is widely expressed in the lung tissue and constitutes an attractive target for the treatment of fibrotic lung diseases. Herein, we present our research toward novel quinoline-based hFP-R antagonists, including synthesis and detailed structure-activity relationship (SAR). Starting from a high-throughput screening (HTS) hit of our corporate compound library, multiple parameter improvements-including increase of the relative oral bioavailability Frel from 3 to ≥100%-led to a highly potent and selective hFP-R antagonist with complete oral absorption from suspension. BAY-6672 (46) represents-to the best of our knowledge-the first reported FP-R antagonist to demonstrate in vivo efficacy in a preclinical animal model of lung fibrosis, thus paving the way for a new treatment option in IPF.


Assuntos
Fibrose Pulmonar Idiopática/tratamento farmacológico , Pulmão/efeitos dos fármacos , Quinolinas/síntese química , Receptores de Prostaglandina/antagonistas & inibidores , Administração Oral , Animais , Modelos Animais de Doenças , Humanos , Fibrose Pulmonar Idiopática/metabolismo , Pulmão/metabolismo , Pulmão/patologia , Masculino , Camundongos , Estrutura Molecular , Quinolinas/química , Quinolinas/uso terapêutico , Ratos , Ratos Wistar , Relação Estrutura-Atividade
2.
J Environ Qual ; 38(6): 2322-33, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19875788

RESUMO

Algal-available phosphorus (Paa) in river water and wastewater entering the Gulf of Finland (a Baltic Sea sub-basin) was estimated by a fresh-water and a brackish-water modification of the dual-culture algal assay. The assay results were further related to those obtained by routine chemical analyses. According to the brackish-water assay, an average of 44% (range, 9-88%) of total phosphorus (TP) in water samples from the Neva, Kymijoki, and Narva rivers consisted of Paa, whereas the mean value given by the fresh-water assay was 22% (range, 0-48%). Phaeodactylum tricornutum Bohlin, which was used as the test alga in the brackish-water assay, had higher phosphoesterase activity and P affinity than did Pseudokirchneriella subcapitata Korschikov, which was used in the fresh-water assay. This difference may explain the higher values of Paa shown by the brackish-water assay. Of the analytical P forms, total dissolved P best approximated, yet underestimated, the Paa in river water samples. As for the biologically purified wastewaters of the city of St. Petersburg, both assays suggested that about 80% of TP (range, 59-103%) was available. That the assays gave similar results was probably due to the fact that most of the P in the wastewater samples was in the form of readily available dissolved reactive P. In untreated urban wastewaters, the mean proportion of Paa in TP was 46% (range, 19-76%). Although the true Paa may not be obtained by any assay, our findings corroborate the view that severe underestimation may occur if the test conditions are suboptimal for the release and uptake of P.


Assuntos
Eucariotos/metabolismo , Fósforo/análise , Rios/química , Esgotos/análise , Oceano Atlântico , Monitoramento Ambiental , Finlândia , Fósforo/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA